Welcome, Guest. Please login or register.
June 25, 2024, 11:29:16 am

Login with username, password and session length

  • Total Members: 6309
  • Latest: Vicki
  • Total Posts: 55130
  • Total Topics: 4851
  • Online Today: 73
  • Online Ever: 1314
  • (June 22, 2016, 05:23:42 am)
Users Online
Users: 0
Guests: 33
Total: 33


Welcome to the Hep Forums, a round-the-clock discussion area for people who have Fatty Liver Disease, Hepatitis B, C or a co-infection, their friends and family and others with questions about hepatitis and liver health. Check in frequently to read what others have to say, post your comments, and hopefully learn more about how you can reach your own health goals.

Privacy Warning: Please realize that these forums are open to all, and are fully searchable via Google and other search engines. If this concerns you, then do not use a username or avatar that are self-identifying in any way. We do not allow the deletion of anything you post in these forums, so think before you post.
  • The information shared in these forums, by moderators and members, is designed to complement, not replace, the relationship between an individual and his/her own physician.
  • All members of these forums are, by default, not considered to be licensed medical providers. If otherwise, users must clearly define themselves as such.
  • Product advertisement (including links); banners; and clinical trial, study or survey participation—is strictly prohibited by forums members unless permission has been secured from the Hep Forum Moderators.
Finished Reading This? You can collapse this or any other box on this page by clicking the symbol in each box.

Author Topic: Bubonic Plague–Driven Gene Tied to Less Fibrosis in Those With HIV and Hep C  (Read 8052 times)

0 Members and 1 Guest are viewing this topic.

Offline Hep Editors

  • Member
  • Posts: 784
    • Hep Mag
A genetic mutation that may have conferred protection against the 14th-century bubonic plague in Europe is associated with less severe liver fibrosis among those coinfected with HIV and hepatitis C virus (HCV).

Publishing their findings in Clinical Infectious Diseases, researchers studied blood samples from HIV/HCV–coinfected individuals who had contracted the viruses through hemophilia treatments during the 1980s. The scientists analyzed differences in liver fibrosis progression among them based on whether they had a genetic mutation known as the CCR5-delta 32 mutation, which yields a nonfunctioning CCR5 coreceptor on the surface of the immune cells that HIV targets. Most HIV latches onto that coreceptor to begin the process of infecting a cell.

For more...


© 2024 Smart + Strong. All Rights Reserved.   terms of use and your privacy
Smart + Strong® is a registered trademark of CDM Publishing, LLC.